5-Fluorouracil--recent advances in clinical studies
Furue, H.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2612-2615
1987
ISSN/ISBN: 0385-0684 PMID: 3304171 Document Number: 297236
Document emailed within 1 workday
Related Documents
Toide, H.; Akiyoshi, H.; Minato, Y.; Okuda, H.; Fujii, S. 1977: Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil Gan 68(5): 553-560Szczeklik-Franek, A.; Bober, A.; Kubek, M. 1979: Clinical and histological studies of psoriatic lesions treated with 5% 5-fluorouracil ointment Wiadomosci Lekarskie 32(7): 449-456
Ke, M.Y.; Chen, S.P. 1986: Advances in clinical studies of gastrointestinal motility Zhonghua Nei Ke Za Zhi 25(11): 691-693
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Prandota, J.; Sarul, H. 1988: Advances in pharmacokinetic studies and clinical use of antibiotics and various chemotherapeutic agents in children Pediatria Polska 63(6): 397-404
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Pan, W.S.; Hu, J. 1991: Studies of 5-fluorouracil nanocapsules Yao Xue Xue Bao 26(4): 280-285
Akulenko, T.V. 1981: Cytogenetic studies of the effects of 5-fluorouracil in vivo Genetika 17(3): 560-562
Speyer, J.L.; Collins, J.M.; Dedrick, R.L.; Brennan, M.F.; Buckpitt, A.R.; Londer, H.; DeVita, V.T.; Myers, C.E. 1980: Phase i and pharmacological studies of 5-fluorouracil administered intraperitoneally Cancer Research 40(3): 567-572
Tattersall, M.H. 1983: Current studies of methotrexate and 5-fluorouracil and their interaction in human tumor cells Seminars in Oncology 10(2 Suppl. 2): 6-14
Schumacher, K. 2000: Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04 Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(5): 239-240
Shirasaka, T.; Shimamoto, Y.; Kato, T.; Fukushima, M. 1998: Invention of a tumor-selective 5-fluorouracil derivative named S-1 by biochemical modulation of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 371-384
Iigo, M.; Kuretani, K.; Hoshi, A. 1981: Metabolic fate on 1-hexylcarbamoyl-5-fluorouracil and 5-fluorouracil in mice bearing ascites sarcoma 180 Journal of the National Cancer Institute 66(2): 345-349
El Sayed, Y.M.; Sadée, W. 1983: Metabolic activation of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes Cancer Research 43(9): 4039-4044
Yamashita, K.; Mitani, K.; Morishita, Y.; Inoue, K. 1989: The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Part 1): 767-773
Fujii, S.; Kitano, S.; Ikenaka, K.; Fukushima, M.; Nakamura, H.; Maehara, Y.; Shirasaka, T. 1980: Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil Gan 71(1): 100-106
Tamemasa, O.; Tezuka, M. 1983: Antitumor effect of 5-fluorouracil in combination with some additives which stimulate the formation of antineoplastic 5-fluorouracil nucleotides Gan 74(2): 285-290
Sijens, P.E.; Huang, Y.M.; Baldwin, N.J.; Ng, T.C. 1991: 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver Cancer Research 51(5): 1384-1390
Hudes, G.R.; Comis, R.L. 1988: Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancer Seminars in Oncology 15(2 Suppl 2: 41-45
Shaib, W.; Lee, V.; Saif, M.W. 2009: Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity In Vivo 23(5): 821-826